Le Lézard
Classified in: Health, Science and technology
Subjects: SVY, CSR, PET, ESG

IDEXX Releases 2022 Corporate Responsibility Report, Providing Environmental, Social, and Governance Updates


The 2022 report, "Purpose-Driven Progress," introduces a new framework that aligns IDEXX's ESG goals and initiatives with its long-term strategy and Purpose

WESTBROOK, Maine, July 25, 2023 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today published its 2022 Corporate Responsibility Report, highlighting progress against the environmental, social, and governance (ESG) goals it announced last year. The report also introduces a framework to focus and prioritize the company's ESG goals and initiatives. The framework includes three pillars focused on the environmental and social priorities most important to IDEXX's stakeholders and business, underpinned by strong governance, policies, and systems infrastructure.

The Care We Advance
IDEXX brings clarity to a complex world through diagnostic and software solutions to support longer, fuller lives for pets and those who care for them. Key highlights from the 2022 report include these:

The People We Support
IDEXX strives to foster a collaborative and inclusive workplace that empowers employees to develop and grow and find purpose and fulfillment in all they do. Key highlights from the 2022 report include these:

The Planet We Share
IDEXX is committed to reducing its environmental footprint. Key highlights from the 2022 report include these:

"This year's report coincides with IDEXX celebrating its 40th anniversary," said Jay Mazelsky, IDEXX President and Chief Executive Officer. "I feel a deep sense of pride in how we continue to fulfill our Purpose and create long-term value for our stakeholders by advancing care for people and animals, protecting the planet we share, and supporting colleagues and communities where we live and work."

IDEXX's 2022 report once again focuses on IDEXX's key ESG topics in alignment with reporting standards and frameworks, such as those released by the Sustainability Accounting Standards Board and the Task Force on Climate-Related Financial Disclosures as well as our business strategy. Read the 2022 Corporate Responsibility Report here.

About IDEXX
IDEXX is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolving world of veterinary medicine. We support longer, fuller lives for pets by delivering insights and solutions that help the veterinary community around the world make confident decisions?to advance medical care, improve efficiency, and build thriving practices. Our innovations also help ensure the safety of milk and water across the world and maintain the health and well-being of people and livestock. IDEXX Laboratories, Inc. is a member of the S&P 500® Index. Headquartered in Maine, IDEXX employs nearly 11,000 people and offers solutions and products to customers in more than 175 countries and territories. For more information about IDEXX, visit idexx.com.

SOURCE IDEXX Laboratories, Inc.


These press releases may also interest you

at 20:10
We are advised by Hidden River Eating Disorder Residential Treatment that journalists and other readers should disregard the news release, Hidden River Announces Insurance Contract with Blue Cross Blue Shield, issued 16-May-2024 over PR Newswire....

at 20:00
Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, today announced the appointment of Mark S. de Jong, PhD, to the newly created position of Chief Technical Officer (CTO). Dr. de Jong, joins Full-Life with 43...

at 19:20
Whitman-Walker Institute, which leverages research, policy, and education to advance health equity nationwide, says it's standing by to further inform the chair of the U.S. House Committee on Education and the Workforce and others about the strong...

at 18:50
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against Akero Therapeutics, Inc....

at 18:46
Amgen today announced that the U.S. Food and Drug Administration (FDA) has approved IMDELLTRAtm (tarlatamab-dlle) for the...

at 18:42
Housecall Providers, a nonprofit home-based medical organization invites the community to Sellwood Park, Saturday, June 1, from noon ? 4:00 p.m. for an inspiring afternoon of learning, connection and some friendly competition. Toss...



News published on and distributed by: